Delivery Order SPE2DE21D7020-SPE2D625F1KPA
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,795.18 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract employs fixed-price pricing with economic price adjustment terms and is scheduled for completion by July 1, 2025. The award is not set-aside and represents Boston Scientific's continued role as a prime contractor supplying advanced medical devices to federal...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $75,560 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 10, 2025. This fixed-price contract with economic price adjustment provisions represents a non-competitive award with no small business set-aside. As the place of performance is Boston Scientific's headquarters location in...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $4,505.50 by the Defense Health Agency's Medical Supply Chain on August 5, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 12, 2025 and involves performance at Boston Scientific's facility in Marlborough, MA. The award was made without a set-aside designation, allowing the company...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $17,805.09 by the Defense Health Agency's Medical Supply Chain on August 12, 2025, with an ultimate completion date of August 19, 2025. This non-set-aside contract utilizes fixed-price pricing with economic price adjustment terms and is to be performed in Marlborough, MA. Boston Scientific specializes in developing and manufacturing...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a fixed-price delivery order valued at $12,317.30 by the Defense Health Agency's Medical Supply Chain division. The delivery order, designated as a non-set-aside contract with an ultimate completion date of August 27, 2025, represents a continuation of Boston Scientific's role as a critical supplier of advanced medical devices to federal healthcare agencies. The contract is...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- Boston Scientific Corp has been awarded a delivery order valued at $2,762.81 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of August 8, 2025. This fixed-price contract with economic price adjustment represents a non-set-aside award to the prime contractor, with performance taking place at Boston Scientific's headquarters in Marlborough, Massachusetts. As a global medical technology company, Boston Scientific provides critical medical devices and...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F1KPADelivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $8,902.14 for FATHOM-14 medical equipment (200 cm x 10 cm) by the Defense Health Agency's Medical Supply Chain. The contract utilizes fixed-price pricing with economic price adjustment and carries an ultimate completion date of August 27, 2025. This award represents a non-set-aside competitive action, with performance occurring at Boston Scientific's Marlborough facility. As a prime contractor, Boston Scientific supplies specialized medical devices and solutions to federal healthcare agencies, including the Department of Veterans Affairs and Defense Health Agency, leveraging its extensive portfolio of cardiovascular, interventional, and diagnostic medical technologies. This delivery order is likely issued under Boston Scientific's existing Indefinite Delivery Vehicle with the Defense Health Agency, which positions the company as a key supplier of advanced medical technologies to the federal healthcare system. The company maintains a robust track record of federal contract performance, with prior awards encompassing radiation treatment devices, endoscopy stents, neurostimulation systems, and various cardiovascular intervention tools. The relatively modest ceiling value of this particular delivery order reflects the tactical nature of purchase orders within the broader DHA Medical Supply Chain framework, enabling rapid procurement of critical medical equipment to support federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 8/20/25 |